Ricevi le ultime notizie sulle azioni Quanterix con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di QTRX

Ultime notizie per

Quanterix

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

Quanterix Corp

Press Releases

AKOYA BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

Quanterix Expands Reach with IVD and Large Reference Labs

Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

Quanterix Announces Cooperation Agreement with Kent Lake Capital

Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025

Quanterix Releases Financial Results for the Second Quarter of 2025

Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference

Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit

AKYA

QTRX

Atlantic International Corp. - Common Stock

Atlantic International

Bionano Genomics

Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A

Bruker

Codexis

Champions Oncology

Cytek Biosciences

CryoPort

Fortrea Holdings

Harvard Bioscience

MindWalk Holdings

Standard BioTools

Lifecore Biomedical

Mesa Laboratories

Maravai LifeSciences Holdings, Inc. - Class A common stock

Maravai LifeSciences

MaxCyte

Niagen Bioscience

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

Inotiv

OmniAb

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences

Personalis

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Seer

Alpha Teknova

Canaccord Genuity

Leerink Partners

Scotiabank

TD Cowen

Goldman Sachs

Comments

Quanterix Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO